

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | purine nucleobase biosynthetic process (GO:0009113) | 4.66080091 |
| 2 | proteasome assembly (GO:0043248) | 4.56772890 |
| 3 | nucleobase biosynthetic process (GO:0046112) | 4.47391556 |
| 4 | formation of translation preinitiation complex (GO:0001731) | 4.38048097 |
| 5 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.27207973 |
| 6 | ribosome assembly (GO:0042255) | 4.27188528 |
| 7 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.21511160 |
| 8 | respiratory electron transport chain (GO:0022904) | 4.19290173 |
| 9 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.09559781 |
| 10 | electron transport chain (GO:0022900) | 4.09101144 |
| 11 | oxidative phosphorylation (GO:0006119) | 4.05214386 |
| 12 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 4.05172324 |
| 13 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.03571298 |
| 14 | mitotic metaphase plate congression (GO:0007080) | 3.93561409 |
| 15 | termination of RNA polymerase III transcription (GO:0006386) | 3.91357870 |
| 16 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.91357870 |
| 17 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.87829751 |
| 18 | protein maturation by protein folding (GO:0022417) | 3.87200081 |
| 19 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.86494919 |
| 20 | negative regulation of ligase activity (GO:0051352) | 3.86494919 |
| 21 | maturation of SSU-rRNA (GO:0030490) | 3.86230425 |
| 22 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.84230801 |
| 23 | 7-methylguanosine mRNA capping (GO:0006370) | 3.83985695 |
| 24 | ribosome biogenesis (GO:0042254) | 3.80441658 |
| 25 | cullin deneddylation (GO:0010388) | 3.78613515 |
| 26 | rRNA modification (GO:0000154) | 3.77319783 |
| 27 | protein deneddylation (GO:0000338) | 3.76010232 |
| 28 | RNA capping (GO:0036260) | 3.74585304 |
| 29 | 7-methylguanosine RNA capping (GO:0009452) | 3.74585304 |
| 30 | amino acid salvage (GO:0043102) | 3.72764227 |
| 31 | L-methionine salvage (GO:0071267) | 3.72764227 |
| 32 | L-methionine biosynthetic process (GO:0071265) | 3.72764227 |
| 33 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.72215891 |
| 34 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.71582970 |
| 35 | folic acid metabolic process (GO:0046655) | 3.70053009 |
| 36 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.70034749 |
| 37 | tRNA aminoacylation for protein translation (GO:0006418) | 3.68272928 |
| 38 | ribosomal small subunit assembly (GO:0000028) | 3.65414272 |
| 39 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.64749105 |
| 40 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.64222998 |
| 41 | amino acid activation (GO:0043038) | 3.62312854 |
| 42 | tRNA aminoacylation (GO:0043039) | 3.62312854 |
| 43 | ribosomal large subunit biogenesis (GO:0042273) | 3.61909214 |
| 44 | DNA deamination (GO:0045006) | 3.58316922 |
| 45 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.57691615 |
| 46 | positive regulation of ligase activity (GO:0051351) | 3.56028295 |
| 47 | protein complex biogenesis (GO:0070271) | 3.55487949 |
| 48 | respiratory chain complex IV assembly (GO:0008535) | 3.55047455 |
| 49 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.54551227 |
| 50 | DNA replication checkpoint (GO:0000076) | 3.51018127 |
| 51 | ribosomal small subunit biogenesis (GO:0042274) | 3.48690638 |
| 52 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.48108131 |
| 53 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.48108131 |
| 54 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.47720579 |
| 55 | L-serine metabolic process (GO:0006563) | 3.46440541 |
| 56 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.45484095 |
| 57 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.45484095 |
| 58 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.45484095 |
| 59 | protein localization to mitochondrion (GO:0070585) | 3.45473328 |
| 60 | DNA replication initiation (GO:0006270) | 3.42098904 |
| 61 | tricarboxylic acid cycle (GO:0006099) | 3.41896909 |
| 62 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.41348937 |
| 63 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.41348937 |
| 64 | spliceosomal snRNP assembly (GO:0000387) | 3.40965164 |
| 65 | rRNA processing (GO:0006364) | 3.40912320 |
| 66 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.40395689 |
| 67 | maturation of 5.8S rRNA (GO:0000460) | 3.38729501 |
| 68 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.35764809 |
| 69 | serine family amino acid biosynthetic process (GO:0009070) | 3.31103347 |
| 70 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.30759067 |
| 71 | protein neddylation (GO:0045116) | 3.30711251 |
| 72 | NADH metabolic process (GO:0006734) | 3.29590294 |
| 73 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.28977606 |
| 74 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.28843833 |
| 75 | rRNA metabolic process (GO:0016072) | 3.27535634 |
| 76 | DNA strand elongation (GO:0022616) | 3.25039265 |
| 77 | cytochrome complex assembly (GO:0017004) | 3.20473548 |
| 78 | regulation of mitochondrial translation (GO:0070129) | 3.20282072 |
| 79 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.19681774 |
| 80 | regulation of ligase activity (GO:0051340) | 3.19477923 |
| 81 | peptidyl-histidine modification (GO:0018202) | 3.18266044 |
| 82 | protein localization to endoplasmic reticulum (GO:0070972) | 3.17629286 |
| 83 | regulation of translational fidelity (GO:0006450) | 3.16894745 |
| 84 | establishment of viral latency (GO:0019043) | 3.16385466 |
| 85 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.15797056 |
| 86 | NADH dehydrogenase complex assembly (GO:0010257) | 3.15797056 |
| 87 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.15797056 |
| 88 | cellular component biogenesis (GO:0044085) | 3.15775120 |
| 89 | translational initiation (GO:0006413) | 3.15678063 |
| 90 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 3.14341718 |
| 91 | rRNA methylation (GO:0031167) | 3.11374739 |
| 92 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.10875739 |
| 93 | metaphase plate congression (GO:0051310) | 3.10830277 |
| 94 | G1/S transition of mitotic cell cycle (GO:0000082) | 3.10637081 |
| 95 | cell cycle G1/S phase transition (GO:0044843) | 3.10637081 |
| 96 | aerobic respiration (GO:0009060) | 3.09869377 |
| 97 | translation (GO:0006412) | 3.09526830 |
| 98 | inner mitochondrial membrane organization (GO:0007007) | 3.08111093 |
| 99 | termination of RNA polymerase I transcription (GO:0006363) | 3.07703932 |
| 100 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.07457078 |
| 101 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.06611193 |
| 102 | transcription from RNA polymerase I promoter (GO:0006360) | 3.06591321 |
| 103 | glycine metabolic process (GO:0006544) | 3.04209099 |
| 104 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.03938578 |
| 105 | CENP-A containing nucleosome assembly (GO:0034080) | 3.02451691 |
| 106 | mitochondrial transport (GO:0006839) | 3.02085807 |
| 107 | chaperone-mediated protein transport (GO:0072321) | 3.01407236 |
| 108 | methionine biosynthetic process (GO:0009086) | 3.00514555 |
| 109 | translational termination (GO:0006415) | 3.00477272 |
| 110 | transcription from mitochondrial promoter (GO:0006390) | 2.99908224 |
| 111 | Golgi transport vesicle coating (GO:0048200) | 2.99697729 |
| 112 | COPI coating of Golgi vesicle (GO:0048205) | 2.99697729 |
| 113 | establishment of integrated proviral latency (GO:0075713) | 2.99191988 |
| 114 | transcription elongation from RNA polymerase II promoter (GO:0006368) | 2.97408327 |
| 115 | viral transcription (GO:0019083) | 2.97227766 |
| 116 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.96364566 |
| 117 | cotranslational protein targeting to membrane (GO:0006613) | 2.95774400 |
| 118 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.95297828 |
| 119 | ATP synthesis coupled proton transport (GO:0015986) | 2.95169061 |
| 120 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.95169061 |
| 121 | chromatin remodeling at centromere (GO:0031055) | 2.95062753 |
| 122 | regulation of cellular amine metabolic process (GO:0033238) | 2.94397418 |
| 123 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.93607725 |
| 124 | establishment of protein localization to mitochondrion (GO:0072655) | 2.92921584 |
| 125 | tetrahydrofolate metabolic process (GO:0046653) | 2.92113763 |
| 126 | protein targeting to ER (GO:0045047) | 2.91235609 |
| 127 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.89499389 |
| 128 | IMP biosynthetic process (GO:0006188) | 2.89154181 |
| 129 | folic acid-containing compound metabolic process (GO:0006760) | 2.87541597 |
| 130 | aspartate family amino acid biosynthetic process (GO:0009067) | 2.86953047 |
| 131 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.85848344 |
| 132 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.85848344 |
| 133 | pseudouridine synthesis (GO:0001522) | 2.85004280 |
| 134 | protein targeting to mitochondrion (GO:0006626) | 2.84734822 |
| 135 | DNA-templated transcription, elongation (GO:0006354) | 2.84441186 |
| 136 | positive regulation of cell cycle arrest (GO:0071158) | 2.83702529 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.86176855 |
| 2 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.28155427 |
| 3 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.19153145 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.94542286 |
| 5 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.85723635 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.73231948 |
| 7 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.58809515 |
| 8 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.56753670 |
| 9 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.50845537 |
| 10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.25529509 |
| 11 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.00179404 |
| 12 | * E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.92146607 |
| 13 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.87131757 |
| 14 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.84173751 |
| 15 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.81645561 |
| 16 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.63509259 |
| 17 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.63159831 |
| 18 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.52127932 |
| 19 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.44894403 |
| 20 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.43506687 |
| 21 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.40092369 |
| 22 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.38293556 |
| 23 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.37940682 |
| 24 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.34370922 |
| 25 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.32598905 |
| 26 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.23081230 |
| 27 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.19124017 |
| 28 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.17349173 |
| 29 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.15022489 |
| 30 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.06082089 |
| 31 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.05034951 |
| 32 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.99986886 |
| 33 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.99204873 |
| 34 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.98213629 |
| 35 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.95894670 |
| 36 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.93348681 |
| 37 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.88737203 |
| 38 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.87883114 |
| 39 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.86915705 |
| 40 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.85381754 |
| 41 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.84771840 |
| 42 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.80353264 |
| 43 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.77386872 |
| 44 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.71938190 |
| 45 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.67881681 |
| 46 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.67416727 |
| 47 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.65907300 |
| 48 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.65425522 |
| 49 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.58168031 |
| 50 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.54848799 |
| 51 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.50115609 |
| 52 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.49486483 |
| 53 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.48513226 |
| 54 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.43988320 |
| 55 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.42877082 |
| 56 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.40700424 |
| 57 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.35745961 |
| 58 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.35536646 |
| 59 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.34728792 |
| 60 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.34206417 |
| 61 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.34181905 |
| 62 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32171343 |
| 63 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.31093003 |
| 64 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.27895635 |
| 65 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.25194590 |
| 66 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.23921697 |
| 67 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.23915356 |
| 68 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.19066726 |
| 69 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.18518548 |
| 70 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.17631268 |
| 71 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.15583911 |
| 72 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.15412585 |
| 73 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.12583410 |
| 74 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10514610 |
| 75 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.09856940 |
| 76 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08262581 |
| 77 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.05800556 |
| 78 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.04988720 |
| 79 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.02706274 |
| 80 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02570580 |
| 81 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.01228692 |
| 82 | * SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.01137995 |
| 83 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.00750125 |
| 84 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.00747106 |
| 85 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99714382 |
| 86 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.99709472 |
| 87 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.99280883 |
| 88 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.98268428 |
| 89 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.98000286 |
| 90 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.96027914 |
| 91 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.95584266 |
| 92 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.95094110 |
| 93 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.93960304 |
| 94 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.93844365 |
| 95 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.93598282 |
| 96 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.93508959 |
| 97 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.93324676 |
| 98 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.92403255 |
| 99 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.90604222 |
| 100 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.89769622 |
| 101 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.88041758 |
| 102 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.85998224 |
| 103 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.85607276 |
| 104 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.85381796 |
| 105 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.84055900 |
| 106 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.83722563 |
| 107 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.83206456 |
| 108 | * CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.83042248 |
| 109 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.81570274 |
| 110 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.81405043 |
| 111 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.80450138 |
| 112 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.80421945 |
| 113 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.80303228 |
| 114 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.79053462 |
| 115 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.78336906 |
| 116 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.78336906 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 5.64190969 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 4.94657603 |
| 3 | MP0004957_abnormal_blastocyst_morpholog | 4.47531677 |
| 4 | MP0003718_maternal_effect | 3.64772727 |
| 5 | MP0003111_abnormal_nucleus_morphology | 3.62524217 |
| 6 | MP0003077_abnormal_cell_cycle | 3.45853214 |
| 7 | MP0010094_abnormal_chromosome_stability | 3.33948312 |
| 8 | MP0008932_abnormal_embryonic_tissue | 3.10077676 |
| 9 | MP0008057_abnormal_DNA_replication | 2.93954010 |
| 10 | MP0003186_abnormal_redox_activity | 2.75830871 |
| 11 | MP0003123_paternal_imprinting | 2.75402448 |
| 12 | MP0002837_dystrophic_cardiac_calcinosis | 2.56596178 |
| 13 | MP0002139_abnormal_hepatobiliary_system | 2.39210664 |
| 14 | MP0008058_abnormal_DNA_repair | 2.37845791 |
| 15 | MP0008260_abnormal_autophagy | 2.36574469 |
| 16 | MP0001730_embryonic_growth_arrest | 2.35556427 |
| 17 | MP0009840_abnormal_foam_cell | 2.23945476 |
| 18 | MP0004233_abnormal_muscle_weight | 2.17862707 |
| 19 | MP0000372_irregular_coat_pigmentation | 2.14709351 |
| 20 | MP0001529_abnormal_vocalization | 2.10422341 |
| 21 | MP0010234_abnormal_vibrissa_follicle | 2.06001640 |
| 22 | MP0000749_muscle_degeneration | 1.91005144 |
| 23 | MP0005451_abnormal_body_composition | 1.88683271 |
| 24 | MP0003786_premature_aging | 1.85205968 |
| 25 | MP0003941_abnormal_skin_development | 1.81503453 |
| 26 | MP0003195_calcinosis | 1.79781950 |
| 27 | MP0005330_cardiomyopathy | 1.79779745 |
| 28 | MP0005379_endocrine/exocrine_gland_phen | 1.78347714 |
| 29 | MP0006036_abnormal_mitochondrial_physio | 1.77945141 |
| 30 | MP0000350_abnormal_cell_proliferation | 1.77121697 |
| 31 | MP0008007_abnormal_cellular_replicative | 1.76695428 |
| 32 | MP0005360_urolithiasis | 1.69191505 |
| 33 | MP0005365_abnormal_bile_salt | 1.64411654 |
| 34 | MP0005408_hypopigmentation | 1.62960400 |
| 35 | MP0008877_abnormal_DNA_methylation | 1.59991629 |
| 36 | MP0000358_abnormal_cell_content/ | 1.58764404 |
| 37 | MP0006035_abnormal_mitochondrial_morpho | 1.56371846 |
| 38 | MP0001697_abnormal_embryo_size | 1.53403346 |
| 39 | MP0005332_abnormal_amino_acid | 1.45068477 |
| 40 | MP0002269_muscular_atrophy | 1.43861402 |
| 41 | MP0005085_abnormal_gallbladder_physiolo | 1.42529128 |
| 42 | MP0001672_abnormal_embryogenesis/_devel | 1.40469791 |
| 43 | MP0005380_embryogenesis_phenotype | 1.40469791 |
| 44 | MP0009333_abnormal_splenocyte_physiolog | 1.39537904 |
| 45 | MP0002080_prenatal_lethality | 1.37787571 |
| 46 | MP0005058_abnormal_lysosome_morphology | 1.34080224 |
| 47 | MP0000751_myopathy | 1.33538007 |
| 48 | MP0008875_abnormal_xenobiotic_pharmacok | 1.31628054 |
| 49 | MP0010030_abnormal_orbit_morphology | 1.31486314 |
| 50 | MP0001727_abnormal_embryo_implantation | 1.30630270 |
| 51 | MP0004133_heterotaxia | 1.29338122 |
| 52 | MP0000747_muscle_weakness | 1.29057429 |
| 53 | MP0001661_extended_life_span | 1.27731596 |
| 54 | MP0005670_abnormal_white_adipose | 1.24309000 |
| 55 | MP0005075_abnormal_melanosome_morpholog | 1.22953557 |
| 56 | MP0010307_abnormal_tumor_latency | 1.22348129 |
| 57 | MP0005395_other_phenotype | 1.21930924 |
| 58 | MP0001764_abnormal_homeostasis | 1.21727802 |
| 59 | MP0009697_abnormal_copulation | 1.20560837 |
| 60 | MP0003656_abnormal_erythrocyte_physiolo | 1.20179594 |
| 61 | MP0003984_embryonic_growth_retardation | 1.19546778 |
| 62 | MP0000013_abnormal_adipose_tissue | 1.19416433 |
| 63 | MP0001542_abnormal_bone_strength | 1.16429779 |
| 64 | MP0002088_abnormal_embryonic_growth/wei | 1.16027117 |
| 65 | MP0002085_abnormal_embryonic_tissue | 1.14982564 |
| 66 | MP0000313_abnormal_cell_death | 1.12592558 |
| 67 | MP0002210_abnormal_sex_determination | 1.10803808 |
| 68 | MP0000003_abnormal_adipose_tissue | 1.10293203 |
| 69 | MP0005266_abnormal_metabolism | 1.09506202 |
| 70 | MP0008995_early_reproductive_senescence | 1.07447762 |
| 71 | MP0002653_abnormal_ependyma_morphology | 1.05058185 |
| 72 | MP0003221_abnormal_cardiomyocyte_apopto | 1.04848365 |
| 73 | MP0003890_abnormal_embryonic-extraembry | 1.04652143 |
| 74 | MP0003121_genomic_imprinting | 1.04271226 |
| 75 | MP0004145_abnormal_muscle_electrophysio | 1.01710501 |
| 76 | MP0003136_yellow_coat_color | 1.01452260 |
| 77 | MP0001145_abnormal_male_reproductive | 1.01021351 |
| 78 | MP0002160_abnormal_reproductive_system | 1.00958597 |
| 79 | MP0005083_abnormal_biliary_tract | 1.00343346 |
| 80 | MP0001944_abnormal_pancreas_morphology | 1.00080588 |
| 81 | MP0001293_anophthalmia | 1.00040074 |
| 82 | MP0002084_abnormal_developmental_patter | 0.98903870 |
| 83 | MP0003283_abnormal_digestive_organ | 0.98044476 |
| 84 | MP0003646_muscle_fatigue | 0.97808527 |
| 85 | MP0001929_abnormal_gametogenesis | 0.97304622 |
| 86 | MP0002102_abnormal_ear_morphology | 0.95670767 |
| 87 | MP0003315_abnormal_perineum_morphology | 0.93493848 |
| 88 | MP0002090_abnormal_vision | 0.92291647 |
| 89 | MP0002163_abnormal_gland_morphology | 0.92179555 |
| 90 | MP0000678_abnormal_parathyroid_gland | 0.91754039 |
| 91 | MP0000759_abnormal_skeletal_muscle | 0.91395532 |
| 92 | MP0002019_abnormal_tumor_incidence | 0.90130789 |
| 93 | MP0000653_abnormal_sex_gland | 0.89987218 |
| 94 | MP0004036_abnormal_muscle_relaxation | 0.89606950 |
| 95 | MP0005384_cellular_phenotype | 0.89593567 |
| 96 | MP0005389_reproductive_system_phenotype | 0.88238895 |
| 97 | MP0005319_abnormal_enzyme/_coenzyme | 0.87880834 |
| 98 | MP0005501_abnormal_skin_physiology | 0.87696342 |
| 99 | MP0001905_abnormal_dopamine_level | 0.87310513 |
| 100 | MP0003011_delayed_dark_adaptation | 0.86693484 |
| 101 | MP0002132_abnormal_respiratory_system | 0.86676126 |
| 102 | MP0004197_abnormal_fetal_growth/weight/ | 0.85728857 |
| 103 | MP0009780_abnormal_chondrocyte_physiolo | 0.84458662 |
| 104 | MP0005376_homeostasis/metabolism_phenot | 0.83641839 |
| 105 | MP0009672_abnormal_birth_weight | 0.83092962 |
| 106 | MP0002693_abnormal_pancreas_physiology | 0.82740049 |
| 107 | MP0005220_abnormal_exocrine_pancreas | 0.82496631 |
| 108 | MP0002822_catalepsy | 0.82188374 |
| 109 | MP0003119_abnormal_digestive_system | 0.81172278 |
| 110 | MP0004264_abnormal_extraembryonic_tissu | 0.78809171 |
| 111 | MP0002086_abnormal_extraembryonic_tissu | 0.77169680 |
| 112 | MP0002106_abnormal_muscle_physiology | 0.76962540 |
| 113 | MP0003937_abnormal_limbs/digits/tail_de | 0.76611914 |
| 114 | MP0002060_abnormal_skin_morphology | 0.76293781 |
| 115 | MP0001881_abnormal_mammary_gland | 0.75346872 |
| 116 | MP0005636_abnormal_mineral_homeostasis | 0.75171678 |
| 117 | MP0002938_white_spotting | 0.74171894 |
| 118 | MP0002111_abnormal_tail_morphology | 0.73922869 |
| 119 | MP0000598_abnormal_liver_morphology | 0.73861719 |
| 120 | MP0005645_abnormal_hypothalamus_physiol | 0.73852404 |
| 121 | MP0001346_abnormal_lacrimal_gland | 0.73014737 |
| 122 | MP0001243_abnormal_dermal_layer | 0.72908104 |
| 123 | MP0006072_abnormal_retinal_apoptosis | 0.72737909 |
| 124 | MP0002876_abnormal_thyroid_physiology | 0.70861408 |
| 125 | MP0004087_abnormal_muscle_fiber | 0.70380818 |
| 126 | MP0000609_abnormal_liver_physiology | 0.69723067 |
| 127 | MP0005621_abnormal_cell_physiology | 0.69380561 |
| 128 | MP0003950_abnormal_plasma_membrane | 0.69112386 |
| 129 | MP0000750_abnormal_muscle_regeneration | 0.68593616 |
| 130 | MP0004147_increased_porphyrin_level | 0.68392830 |
| 131 | MP0002254_reproductive_system_inflammat | 0.67250272 |
| 132 | MP0004043_abnormal_pH_regulation | 0.67232677 |
| 133 | MP0002796_impaired_skin_barrier | 0.66162757 |
| 134 | MP0004215_abnormal_myocardial_fiber | 0.65700454 |
| 135 | MP0001756_abnormal_urination | 0.64165105 |
| 136 | MP0009643_abnormal_urine_homeostasis | 0.64154584 |
| 137 | MP0001666_abnormal_nutrient_absorption | 0.62147450 |
| 138 | MP0001119_abnormal_female_reproductive | 0.61422062 |
| 139 | MP0002161_abnormal_fertility/fecundity | 0.57922939 |
| 140 | MP0004019_abnormal_vitamin_homeostasis | 0.56653881 |
| 141 | MP0002751_abnormal_autonomic_nervous | 0.55403334 |
| 142 | MP0008873_increased_physiological_sensi | 0.55326633 |
| 143 | MP0006292_abnormal_olfactory_placode | 0.54046376 |
| 144 | MP0003936_abnormal_reproductive_system | 0.51924277 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cerebral hypomyelination (HP:0006808) | 4.54747592 |
| 2 | Birth length less than 3rd percentile (HP:0003561) | 4.40969098 |
| 3 | Abnormality of glycolysis (HP:0004366) | 4.40699122 |
| 4 | Increased serum pyruvate (HP:0003542) | 4.40699122 |
| 5 | Breast hypoplasia (HP:0003187) | 4.22480245 |
| 6 | Carpal bone hypoplasia (HP:0001498) | 4.13516371 |
| 7 | Acute necrotizing encephalopathy (HP:0006965) | 3.83944007 |
| 8 | Increased intramyocellular lipid droplets (HP:0012240) | 3.74268156 |
| 9 | Acute encephalopathy (HP:0006846) | 3.61838369 |
| 10 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.44533132 |
| 11 | Hyperglycinemia (HP:0002154) | 3.42981133 |
| 12 | Rough bone trabeculation (HP:0100670) | 3.42876133 |
| 13 | Mitochondrial inheritance (HP:0001427) | 3.31068948 |
| 14 | Increased muscle lipid content (HP:0009058) | 3.25927625 |
| 15 | Hepatocellular necrosis (HP:0001404) | 3.15850709 |
| 16 | Irregular epiphyses (HP:0010582) | 3.14949614 |
| 17 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.12032099 |
| 18 | Increased CSF lactate (HP:0002490) | 3.11441914 |
| 19 | Degeneration of anterior horn cells (HP:0002398) | 3.03847716 |
| 20 | Abnormality of the anterior horn cell (HP:0006802) | 3.03847716 |
| 21 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 3.00339804 |
| 22 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.98907394 |
| 23 | CNS hypomyelination (HP:0003429) | 2.92422096 |
| 24 | Secondary amenorrhea (HP:0000869) | 2.92275860 |
| 25 | Hypoglycemic coma (HP:0001325) | 2.90804826 |
| 26 | Progressive macrocephaly (HP:0004481) | 2.87871770 |
| 27 | Cerebral edema (HP:0002181) | 2.87869765 |
| 28 | Testicular atrophy (HP:0000029) | 2.83902685 |
| 29 | 3-Methylglutaconic aciduria (HP:0003535) | 2.82073346 |
| 30 | CNS demyelination (HP:0007305) | 2.80693393 |
| 31 | Macrocytic anemia (HP:0001972) | 2.78431561 |
| 32 | Increased serum lactate (HP:0002151) | 2.76767774 |
| 33 | Type I transferrin isoform profile (HP:0003642) | 2.76158128 |
| 34 | Hepatic necrosis (HP:0002605) | 2.74819395 |
| 35 | Abnormal number of erythroid precursors (HP:0012131) | 2.74003034 |
| 36 | Hypokinesia (HP:0002375) | 2.73972676 |
| 37 | Abnormality of the labia minora (HP:0012880) | 2.72659739 |
| 38 | Oral leukoplakia (HP:0002745) | 2.71245369 |
| 39 | Impulsivity (HP:0100710) | 2.70453996 |
| 40 | Hypobetalipoproteinemia (HP:0003563) | 2.70386812 |
| 41 | Abnormal trabecular bone morphology (HP:0100671) | 2.67512264 |
| 42 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.67442888 |
| 43 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.67442888 |
| 44 | Lethargy (HP:0001254) | 2.57055881 |
| 45 | Rhabdomyolysis (HP:0003201) | 2.56380104 |
| 46 | Abnormality of glycine metabolism (HP:0010895) | 2.54778620 |
| 47 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.54778620 |
| 48 | Nemaline bodies (HP:0003798) | 2.52869709 |
| 49 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.52737625 |
| 50 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.51201086 |
| 51 | Reticulocytopenia (HP:0001896) | 2.51196837 |
| 52 | Absent radius (HP:0003974) | 2.49378804 |
| 53 | Megaloblastic anemia (HP:0001889) | 2.48911186 |
| 54 | Abnormal gallbladder physiology (HP:0012438) | 2.48089695 |
| 55 | Cholecystitis (HP:0001082) | 2.48089695 |
| 56 | Hyperglycinuria (HP:0003108) | 2.47812003 |
| 57 | Multiple enchondromatosis (HP:0005701) | 2.47196502 |
| 58 | Abnormality of serum amino acid levels (HP:0003112) | 2.46795057 |
| 59 | Abnormal protein glycosylation (HP:0012346) | 2.46455939 |
| 60 | Abnormal glycosylation (HP:0012345) | 2.46455939 |
| 61 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.46455939 |
| 62 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.46455939 |
| 63 | Ragged-red muscle fibers (HP:0003200) | 2.45693913 |
| 64 | Leukodystrophy (HP:0002415) | 2.45030873 |
| 65 | Premature ovarian failure (HP:0008209) | 2.43793211 |
| 66 | Trismus (HP:0000211) | 2.43087784 |
| 67 | Lactic acidosis (HP:0003128) | 2.42984118 |
| 68 | Respiratory failure (HP:0002878) | 2.41505636 |
| 69 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.41456847 |
| 70 | Progressive muscle weakness (HP:0003323) | 2.38345602 |
| 71 | Increased hepatocellular lipid droplets (HP:0006565) | 2.36975513 |
| 72 | Patellar aplasia (HP:0006443) | 2.36491532 |
| 73 | Gout (HP:0001997) | 2.33288363 |
| 74 | Generalized aminoaciduria (HP:0002909) | 2.33066854 |
| 75 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.32072133 |
| 76 | Absent epiphyses (HP:0010577) | 2.32072133 |
| 77 | Spastic paraparesis (HP:0002313) | 2.31001533 |
| 78 | Lipid accumulation in hepatocytes (HP:0006561) | 2.30822863 |
| 79 | Postnatal microcephaly (HP:0005484) | 2.30668124 |
| 80 | Aplasia involving forearm bones (HP:0009822) | 2.29771801 |
| 81 | Absent forearm bone (HP:0003953) | 2.29771801 |
| 82 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.27850541 |
| 83 | Reduced antithrombin III activity (HP:0001976) | 2.27561895 |
| 84 | Exercise-induced muscle cramps (HP:0003710) | 2.26823141 |
| 85 | Small epiphyses (HP:0010585) | 2.24701482 |
| 86 | Muscle fiber inclusion bodies (HP:0100299) | 2.23767147 |
| 87 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.23734077 |
| 88 | Prolonged neonatal jaundice (HP:0006579) | 2.22834721 |
| 89 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.22380172 |
| 90 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.21378714 |
| 91 | Emotional lability (HP:0000712) | 2.19800319 |
| 92 | Microretrognathia (HP:0000308) | 2.19716258 |
| 93 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.19107379 |
| 94 | Renal Fanconi syndrome (HP:0001994) | 2.16100066 |
| 95 | Delusions (HP:0000746) | 2.16035267 |
| 96 | Hypoglycemic seizures (HP:0002173) | 2.14895451 |
| 97 | Myoglobinuria (HP:0002913) | 2.10517060 |
| 98 | Ketoacidosis (HP:0001993) | 2.10444499 |
| 99 | Upper limb muscle weakness (HP:0003484) | 2.10426557 |
| 100 | Exercise intolerance (HP:0003546) | 2.10395890 |
| 101 | Personality changes (HP:0000751) | 2.06337813 |
| 102 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.05375750 |
| 103 | Dicarboxylic aciduria (HP:0003215) | 2.05375750 |
| 104 | Microvesicular hepatic steatosis (HP:0001414) | 2.03751328 |
| 105 | Abnormality of the umbilical cord (HP:0010881) | 2.03633630 |
| 106 | Aplastic anemia (HP:0001915) | 2.01808535 |
| 107 | Optic disc pallor (HP:0000543) | 2.00225247 |
| 108 | Abnormality of renal resorption (HP:0011038) | 2.00157425 |
| 109 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.99881920 |
| 110 | Methylmalonic aciduria (HP:0012120) | 1.99762262 |
| 111 | Horseshoe kidney (HP:0000085) | 1.97995601 |
| 112 | Dysautonomia (HP:0002459) | 1.96487778 |
| 113 | Sparse eyelashes (HP:0000653) | 1.96359428 |
| 114 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.95661543 |
| 115 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.94500300 |
| 116 | Death in infancy (HP:0001522) | 1.94118862 |
| 117 | Exertional dyspnea (HP:0002875) | 1.93208862 |
| 118 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.92980254 |
| 119 | Pancytopenia (HP:0001876) | 1.92857558 |
| 120 | Abnormality of placental membranes (HP:0011409) | 1.92047713 |
| 121 | Amniotic constriction ring (HP:0009775) | 1.92047713 |
| 122 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.90881942 |
| 123 | Premature graying of hair (HP:0002216) | 1.89669889 |
| 124 | Agnosia (HP:0010524) | 1.88010565 |
| 125 | Palpitations (HP:0001962) | 1.87965424 |
| 126 | Symptomatic seizures (HP:0011145) | 1.87917963 |
| 127 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.87570749 |
| 128 | Poor head control (HP:0002421) | 1.87121004 |
| 129 | Abnormal gallbladder morphology (HP:0012437) | 1.86324865 |
| 130 | Stenosis of the external auditory canal (HP:0000402) | 1.85872719 |
| 131 | Ureteral duplication (HP:0000073) | 1.85615031 |
| 132 | Delayed epiphyseal ossification (HP:0002663) | 1.85522133 |
| 133 | Glossoptosis (HP:0000162) | 1.84956990 |
| 134 | Abnormality of urine glucose concentration (HP:0011016) | 1.83532725 |
| 135 | Glycosuria (HP:0003076) | 1.83532725 |
| 136 | Autoamputation (HP:0001218) | 1.82393657 |
| 137 | Hyperammonemia (HP:0001987) | 1.82171482 |
| 138 | Flat capital femoral epiphysis (HP:0003370) | 1.81391334 |
| 139 | Neoplasm of the adrenal gland (HP:0100631) | 1.80356792 |
| 140 | Septate vagina (HP:0001153) | 1.78431837 |
| 141 | Respiratory difficulties (HP:0002880) | 1.78302198 |
| 142 | Abnormality of methionine metabolism (HP:0010901) | 1.78122921 |
| 143 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.76000619 |
| 144 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.76000619 |
| 145 | Exercise-induced myalgia (HP:0003738) | 1.73652688 |
| 146 | X-linked dominant inheritance (HP:0001423) | 1.73422210 |
| 147 | Methylmalonic acidemia (HP:0002912) | 1.73214690 |
| 148 | Hyperalaninemia (HP:0003348) | 1.73158021 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 5.95452405 |
| 2 | VRK2 | 4.29567157 |
| 3 | WEE1 | 4.05664169 |
| 4 | EIF2AK1 | 3.48889492 |
| 5 | NME2 | 3.10939167 |
| 6 | STK16 | 2.96314364 |
| 7 | CDC7 | 2.52156616 |
| 8 | TESK2 | 2.44097049 |
| 9 | EIF2AK3 | 2.43773014 |
| 10 | TSSK6 | 2.40990741 |
| 11 | PLK4 | 2.31225416 |
| 12 | SRPK1 | 2.26524133 |
| 13 | ARAF | 2.05209321 |
| 14 | BRSK2 | 2.04331892 |
| 15 | PBK | 2.01586568 |
| 16 | TTK | 1.91486139 |
| 17 | NEK2 | 1.88231193 |
| 18 | MAP3K12 | 1.78337385 |
| 19 | BRAF | 1.77142928 |
| 20 | PNCK | 1.73253114 |
| 21 | PLK1 | 1.70267014 |
| 22 | VRK1 | 1.69478722 |
| 23 | BCKDK | 1.69406154 |
| 24 | TRIM28 | 1.64648463 |
| 25 | NEK1 | 1.62974785 |
| 26 | PLK3 | 1.58303969 |
| 27 | EPHA2 | 1.58234244 |
| 28 | ACVR1B | 1.57649991 |
| 29 | PASK | 1.53618437 |
| 30 | AURKA | 1.47403141 |
| 31 | MST4 | 1.43651114 |
| 32 | AKT3 | 1.42809732 |
| 33 | TLK1 | 1.35416925 |
| 34 | WNK3 | 1.32335423 |
| 35 | MKNK1 | 1.30844092 |
| 36 | PIM2 | 1.27439845 |
| 37 | PHKG1 | 1.25634938 |
| 38 | PHKG2 | 1.25634938 |
| 39 | AURKB | 1.20193371 |
| 40 | BRSK1 | 1.17903345 |
| 41 | OBSCN | 1.16759765 |
| 42 | BCR | 1.08669179 |
| 43 | DYRK3 | 1.08164902 |
| 44 | NME1 | 1.07357716 |
| 45 | CDK7 | 1.06442542 |
| 46 | SMG1 | 1.03982568 |
| 47 | OXSR1 | 1.03202262 |
| 48 | CHEK2 | 1.02602273 |
| 49 | DAPK1 | 1.01474399 |
| 50 | ERBB4 | 0.95382242 |
| 51 | CDK8 | 0.94504441 |
| 52 | CSNK1G3 | 0.92911570 |
| 53 | PAK1 | 0.92528693 |
| 54 | MUSK | 0.91725487 |
| 55 | DYRK2 | 0.90547822 |
| 56 | MAP3K8 | 0.90147477 |
| 57 | RPS6KB2 | 0.90147465 |
| 58 | LATS2 | 0.89494536 |
| 59 | LIMK1 | 0.88155462 |
| 60 | RPS6KA4 | 0.88151304 |
| 61 | PAK4 | 0.88091105 |
| 62 | ABL2 | 0.85967651 |
| 63 | TESK1 | 0.84714268 |
| 64 | MET | 0.83976921 |
| 65 | CCNB1 | 0.80861646 |
| 66 | LRRK2 | 0.79966904 |
| 67 | MKNK2 | 0.79588075 |
| 68 | TAF1 | 0.77942901 |
| 69 | STK39 | 0.76796266 |
| 70 | CSNK2A1 | 0.76592306 |
| 71 | ATR | 0.76444244 |
| 72 | MST1R | 0.76187385 |
| 73 | MAP4K2 | 0.73721072 |
| 74 | CSNK2A2 | 0.73452182 |
| 75 | CDK4 | 0.72713028 |
| 76 | CHEK1 | 0.72507561 |
| 77 | PDK2 | 0.72430650 |
| 78 | PDK3 | 0.70222716 |
| 79 | PDK4 | 0.70222716 |
| 80 | MELK | 0.70132856 |
| 81 | MYLK | 0.67014258 |
| 82 | CSNK1G1 | 0.66537418 |
| 83 | MAP3K11 | 0.65169763 |
| 84 | STK38L | 0.65087544 |
| 85 | RPS6KA5 | 0.63073959 |
| 86 | CDK19 | 0.61793613 |
| 87 | DAPK3 | 0.60857875 |
| 88 | AKT2 | 0.60803263 |
| 89 | CSNK1A1L | 0.58168513 |
| 90 | TAOK2 | 0.53939952 |
| 91 | MAP2K6 | 0.52787496 |
| 92 | STK3 | 0.51883648 |
| 93 | ERBB3 | 0.49413337 |
| 94 | ALK | 0.48511147 |
| 95 | MAP3K3 | 0.47400160 |
| 96 | ILK | 0.47396954 |
| 97 | PRKCI | 0.46488077 |
| 98 | CDK2 | 0.46465853 |
| 99 | MOS | 0.44530539 |
| 100 | MAPKAPK3 | 0.41733982 |
| 101 | CSNK1E | 0.41515926 |
| 102 | WNK4 | 0.40537010 |
| 103 | ZAK | 0.39025998 |
| 104 | STK4 | 0.37941856 |
| 105 | PIM1 | 0.37705940 |
| 106 | CLK1 | 0.37232985 |
| 107 | CSNK1G2 | 0.36988202 |
| 108 | PAK3 | 0.36352454 |
| 109 | EIF2AK2 | 0.34872496 |
| 110 | KDR | 0.34825529 |
| 111 | RAF1 | 0.34683066 |
| 112 | CDK1 | 0.33797473 |
| 113 | PRKD3 | 0.32878611 |
| 114 | CDK14 | 0.32738388 |
| 115 | FLT3 | 0.32034150 |
| 116 | ATM | 0.31323011 |
| 117 | SCYL2 | 0.31225666 |
| 118 | MAPKAPK5 | 0.30837211 |
| 119 | PLK2 | 0.27287143 |
| 120 | MAP3K9 | 0.27217999 |
| 121 | CDK11A | 0.27063064 |
| 122 | CDK15 | 0.27053856 |
| 123 | STK10 | 0.26778325 |
| 124 | GRK1 | 0.26455341 |
| 125 | CDK18 | 0.26278330 |
| 126 | CAMK2G | 0.24690541 |
| 127 | CAMK2D | 0.24626009 |
| 128 | IRAK3 | 0.23899021 |
| 129 | PIK3CG | 0.19495662 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.42273499 |
| 2 | RNA polymerase_Homo sapiens_hsa03020 | 3.65862509 |
| 3 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.33486741 |
| 4 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.17126456 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 3.00711424 |
| 6 | DNA replication_Homo sapiens_hsa03030 | 2.85386468 |
| 7 | Mismatch repair_Homo sapiens_hsa03430 | 2.49159190 |
| 8 | RNA transport_Homo sapiens_hsa03013 | 2.45852639 |
| 9 | Protein export_Homo sapiens_hsa03060 | 2.38394909 |
| 10 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.34372628 |
| 11 | Spliceosome_Homo sapiens_hsa03040 | 2.19384127 |
| 12 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.08026561 |
| 13 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.06732214 |
| 14 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.05099924 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.05024498 |
| 16 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.01359570 |
| 17 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.95676172 |
| 18 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.91427340 |
| 19 | Homologous recombination_Homo sapiens_hsa03440 | 1.76371996 |
| 20 | Base excision repair_Homo sapiens_hsa03410 | 1.72343541 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.68005104 |
| 22 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.62782825 |
| 23 | Basal transcription factors_Homo sapiens_hsa03022 | 1.61308584 |
| 24 | Parkinsons disease_Homo sapiens_hsa05012 | 1.61192443 |
| 25 | Cell cycle_Homo sapiens_hsa04110 | 1.60096759 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.43757648 |
| 27 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.42786108 |
| 28 | Huntingtons disease_Homo sapiens_hsa05016 | 1.35136668 |
| 29 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.34021638 |
| 30 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.29986128 |
| 31 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.28520240 |
| 32 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.27453426 |
| 33 | Purine metabolism_Homo sapiens_hsa00230 | 1.22142034 |
| 34 | RNA degradation_Homo sapiens_hsa03018 | 1.22039354 |
| 35 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.15799538 |
| 36 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.07981594 |
| 37 | Carbon metabolism_Homo sapiens_hsa01200 | 1.07560001 |
| 38 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.06762931 |
| 39 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.04713257 |
| 40 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.04367374 |
| 41 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98852569 |
| 42 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.98646088 |
| 43 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.97951746 |
| 44 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.97354960 |
| 45 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.97295523 |
| 46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.96265924 |
| 47 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.94612133 |
| 48 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.91763432 |
| 49 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.91379096 |
| 50 | Alzheimers disease_Homo sapiens_hsa05010 | 0.89822697 |
| 51 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.89787862 |
| 52 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.88345959 |
| 53 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.85633873 |
| 54 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.83254040 |
| 55 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.82048862 |
| 56 | Galactose metabolism_Homo sapiens_hsa00052 | 0.81378263 |
| 57 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.80361654 |
| 58 | Metabolic pathways_Homo sapiens_hsa01100 | 0.79648690 |
| 59 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.78063265 |
| 60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.77183865 |
| 61 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.75890029 |
| 62 | Sulfur relay system_Homo sapiens_hsa04122 | 0.75807788 |
| 63 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.75186635 |
| 64 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.74850400 |
| 65 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.72569768 |
| 66 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.71440231 |
| 67 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.71340155 |
| 68 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70284270 |
| 69 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.69229988 |
| 70 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.68788839 |
| 71 | Peroxisome_Homo sapiens_hsa04146 | 0.68327697 |
| 72 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.67962876 |
| 73 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.62056830 |
| 74 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.62041685 |
| 75 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.59808115 |
| 76 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.59752943 |
| 77 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.59658593 |
| 78 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.58248225 |
| 79 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.56480471 |
| 80 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.55217115 |
| 81 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.55046587 |
| 82 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.54980589 |
| 83 | Histidine metabolism_Homo sapiens_hsa00340 | 0.54638674 |
| 84 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.54336696 |
| 85 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.52803516 |
| 86 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.52586468 |
| 87 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.49610594 |
| 88 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.48963739 |
| 89 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.46393803 |
| 90 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.46220095 |
| 91 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.45773771 |
| 92 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.44540255 |
| 93 | Retinol metabolism_Homo sapiens_hsa00830 | 0.38488626 |
| 94 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.37757307 |
| 95 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.37248298 |
| 96 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.36366064 |
| 97 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.35945163 |
| 98 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.33161610 |
| 99 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32766284 |
| 100 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.31328441 |
| 101 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.31008951 |
| 102 | Lysosome_Homo sapiens_hsa04142 | 0.30998097 |
| 103 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30916850 |
| 104 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.28138145 |
| 105 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.26757287 |
| 106 | Phagosome_Homo sapiens_hsa04145 | 0.25537924 |
| 107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23588517 |
| 108 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.13692605 |
| 109 | Other glycan degradation_Homo sapiens_hsa00511 | 0.11021737 |
| 110 | Circadian rhythm_Homo sapiens_hsa04710 | 0.09996992 |
| 111 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.08549063 |
| 112 | Alcoholism_Homo sapiens_hsa05034 | 0.07255809 |
| 113 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.06532471 |

